TY - JOUR
T1 - Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways
AU - McMillan, J.
AU - Fatehi-Sedeh, S.
AU - Sylvia, V. L.
AU - Bingham, V.
AU - Zhong, M.
AU - Boyan, B. D.
AU - Schwartz, Z.
N1 - Funding Information:
This work was supported by NSF EEC 9731643, the Price Gilbert, Jr. Foundation, the Georgia Research Alliance, and the Presidential Undergraduate Research Scholars Award Program at the Georgia Institute of Technology.
PY - 2006/4
Y1 - 2006/4
N2 - Both male and female rat growth plate cartilage cells possess estrogen receptors (ERs), but 17β-estradiol (E2) activates protein kinase C (PKC) and PKC-dependent biological responses to E2 only in cells from female animals. PKC signaling can elicit genomic responses via mitogen activated protein kinase (MAPK) and E2 has been shown to activate ERK MAPK in many cells, suggesting that MAPK may play a role in growth plate chondrocytes as well. We tested if E2 increases MAPK activity and if so, whether the response is limited to female cells, if it is PKC-dependent, and if the mechanism involves traditional ER pathways. We also determined the contribution of MAPK to the biological response of growth plate chondrocytes and assessed the relative contributions of ERK, p38 and JNK MAPKs. Female rat costochondral cartilage cells were treated with E2 and MAPK-specific activity determined in cell layer lysates. The mechanism of MAPK activation was determined by treating the cells with E2 conjugated to bovine serum albumin (E2-BSA) to assess if membrane receptors were involved; stereospecificity was determined using 17α-estradiol; PKC and phospholipase C (PLC) dependence was determined using specific inhibitors; and the ER agonist diethylstilbestrol, the ER antagonist ICI 182780, and tamoxifen were used to assess the role of traditional ER pathways. E2 regulation of ERK1/2 MAPK was assessed and the relative roles of ERK1/2, p38 and JNK MAPKs determined using specific inhibitors. E2 caused a rapid dose-dependent activation of MAPK that was greatest in cells treated for 9 min with 10-9 M hormone; activity remained elevated for 3 h. E2's effect on MAPK was stereospecific and comparable to that of E2-BSA. It was insensitive to DES and ICI 182780, dependent on PKC and PLC, blocked by tamoxifen and it did not require gene transcription or translation. E2 had no effect on ERK1 or ERK2 mRNA or protein but it caused a rapid phosphorylation of ERK1/2 at 9 min. Inhibition of ERK1/2 and p38 MAPK reduced the stimulatory effects of E2 on alkaline phosphatase activity and [35S]-sulfate incorporation. These results suggest that E2 regulates MAPK through a sex-specific membrane-mediated mechanism that does not involve cytosolic ERs in a traditional sense and that ERK1/2 and p38 mediate the downstream biological effects of the hormone.
AB - Both male and female rat growth plate cartilage cells possess estrogen receptors (ERs), but 17β-estradiol (E2) activates protein kinase C (PKC) and PKC-dependent biological responses to E2 only in cells from female animals. PKC signaling can elicit genomic responses via mitogen activated protein kinase (MAPK) and E2 has been shown to activate ERK MAPK in many cells, suggesting that MAPK may play a role in growth plate chondrocytes as well. We tested if E2 increases MAPK activity and if so, whether the response is limited to female cells, if it is PKC-dependent, and if the mechanism involves traditional ER pathways. We also determined the contribution of MAPK to the biological response of growth plate chondrocytes and assessed the relative contributions of ERK, p38 and JNK MAPKs. Female rat costochondral cartilage cells were treated with E2 and MAPK-specific activity determined in cell layer lysates. The mechanism of MAPK activation was determined by treating the cells with E2 conjugated to bovine serum albumin (E2-BSA) to assess if membrane receptors were involved; stereospecificity was determined using 17α-estradiol; PKC and phospholipase C (PLC) dependence was determined using specific inhibitors; and the ER agonist diethylstilbestrol, the ER antagonist ICI 182780, and tamoxifen were used to assess the role of traditional ER pathways. E2 regulation of ERK1/2 MAPK was assessed and the relative roles of ERK1/2, p38 and JNK MAPKs determined using specific inhibitors. E2 caused a rapid dose-dependent activation of MAPK that was greatest in cells treated for 9 min with 10-9 M hormone; activity remained elevated for 3 h. E2's effect on MAPK was stereospecific and comparable to that of E2-BSA. It was insensitive to DES and ICI 182780, dependent on PKC and PLC, blocked by tamoxifen and it did not require gene transcription or translation. E2 had no effect on ERK1 or ERK2 mRNA or protein but it caused a rapid phosphorylation of ERK1/2 at 9 min. Inhibition of ERK1/2 and p38 MAPK reduced the stimulatory effects of E2 on alkaline phosphatase activity and [35S]-sulfate incorporation. These results suggest that E2 regulates MAPK through a sex-specific membrane-mediated mechanism that does not involve cytosolic ERs in a traditional sense and that ERK1/2 and p38 mediate the downstream biological effects of the hormone.
KW - 17β-Estradiol
KW - ERK
KW - Growth plate chondrocytes
KW - JNK
KW - MAP kinase
KW - Sex-specificity
KW - p38
UR - http://www.scopus.com/inward/record.url?scp=33646533981&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646533981&partnerID=8YFLogxK
U2 - 10.1016/j.bbamcr.2006.02.010
DO - 10.1016/j.bbamcr.2006.02.010
M3 - Article
C2 - 16713447
AN - SCOPUS:33646533981
VL - 1763
SP - 381
EP - 392
JO - Biochimica et Biophysica Acta - Molecular Cell Research
JF - Biochimica et Biophysica Acta - Molecular Cell Research
SN - 0167-4889
IS - 4
ER -